Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1204

1.

Characteristic fast H- ion conduction in oxygen-substituted lanthanum hydride.

Fukui K, Iimura S, Tada T, Fujitsu S, Sasase M, Tamatsukuri H, Honda T, Ikeda K, Otomo T, Hosono H.

Nat Commun. 2019 Jun 12;10(1):2578. doi: 10.1038/s41467-019-10492-7.

PMID:
31189877
2.

The course of elderly patients with persistent hepatitis C virus infection without hepatocellular carcinoma.

Mizuno K, Toyoda H, Yasuda S, Tada T, Kumada T, Sone Y, Tanaka J.

J Gastroenterol. 2019 Jun 3. doi: 10.1007/s00535-019-01595-5. [Epub ahead of print]

PMID:
31161311
3.

Sex Differences in Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism - From the COMMAND VTE Registry.

Yoshikawa Y, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Circ J. 2019 May 28. doi: 10.1253/circj.CJ-19-0229. [Epub ahead of print]

4.

Emergence of carbapenem-resistant Pseudomonas asiatica producing NDM-1 and VIM-2 metallo-β-lactamases in Myanmar.

Tohya M, Tada T, Watanabe S, Kuwahara-Arai K, Zin KN, Zaw NN, Aung MY, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00475-19. doi: 10.1128/AAC.00475-19. [Epub ahead of print]

PMID:
31138570
5.

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Cancer Med. 2019 May 24. doi: 10.1002/cam4.2241. [Epub ahead of print]

6.

Trends and Efficacy of Interferon-Free Anti-hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.

Toyoda H, Atsukawa M, Uojima H, Nozaki A, Tamai H, Takaguchi K, Fujioka S, Nakamuta M, Tada T, Yasuda S, Chuma M, Senoh T, Tsutsui A, Yamashita N, Hiraoka A, Michitaka K, Shima T, Akahane T, Itobayashi E, Watanabe T, Ikeda H, Iio E, Fukunishi S, Asano T, Tachi Y, Ikegami T, Tsuji K, Abe H, Kato K, Mikami S, Okubo H, Shimada N, Ishikawa T, Matsumoto Y, Itokawa N, Arai T, Tsubota A, Iwakiri K, Tanaka Y, Kumada T.

Open Forum Infect Dis. 2019 Apr 15;6(5):ofz185. doi: 10.1093/ofid/ofz185. eCollection 2019 May.

7.

Discovery of hexagonal ternary phase Ti2InB2 and its evolution to layered boride TiB.

Wang J, Ye TN, Gong Y, Wu J, Miao N, Tada T, Hosono H.

Nat Commun. 2019 May 23;10(1):2284. doi: 10.1038/s41467-019-10297-8.

8.

Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease.

Tada T, Toyoda H, Sone Y, Yasuda S, Miyake N, Kumada T, Tanaka J.

J Gastroenterol Hepatol. 2019 May 21. doi: 10.1111/jgh.14734. [Epub ahead of print]

PMID:
31115065
9.

Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model.

Tada T, Toyoda H, Yasuda S, Miyake N, Kumada T, Kurisu A, Ohisa M, Akita T, Tanaka J.

Eur J Gastroenterol Hepatol. 2019 May 6. doi: 10.1097/MEG.0000000000001434. [Epub ahead of print]

PMID:
31082998
10.

Classification for invasion depth of esophageal squamous cell carcinoma using a deep neural network compared with experienced endoscopists.

Nakagawa K, Ishihara R, Aoyama K, Ohmori M, Nakahira H, Matsuura N, Shichijo S, Nishida T, Yamada T, Yamaguchi S, Ogiyama H, Egawa S, Kishida O, Tada T.

Gastrointest Endosc. 2019 May 8. pii: S0016-5107(19)31675-X. doi: 10.1016/j.gie.2019.04.245. [Epub ahead of print]

PMID:
31077698
11.

Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Who Achieved Sustained Virologic Response.

Toyoda H, Tada T, Yasuda S, Mizuno K, Ito T, Kumada T.

Clin Infect Dis. 2019 May 6. pii: ciz359. doi: 10.1093/cid/ciz359. [Epub ahead of print]

PMID:
31056696
12.

Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis.

Hiraoka A, Kumada T, Tsuji K, Takaguchi K, Itobayashi E, Kariyama K, Ochi H, Tajiri K, Hirooka M, Shimada N, Ishikawa T, Tachi Y, Tada T, Toyoda H, Nouso K, Joko K, Hiasa Y, Michitaka K, Kudo M.

Liver Cancer. 2019 Mar;8(2):121-129. doi: 10.1159/000488778. Epub 2018 Jun 11.

13.

Clinical usefulness of ramucirumab plus paclitaxel for unresectable and recurrent gastric cancer.

Hayase S, Yamada L, Ujiie D, Nirei A, Tada T, Hanayama H, Monma T, Saze Z, Ohki S, Kono K.

Fukushima J Med Sci. 2019;65(1):6-12. doi: 10.5387/fms.2018-12.

14.

Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET.

Takahashi M, Tada T, Nakamura T, Koyama K, Momose T.

Am J Alzheimers Dis Other Demen. 2019 Apr 9:1533317519841192. doi: 10.1177/1533317519841192. [Epub ahead of print]

PMID:
30966759
15.

A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.

Hishinuma T, Tada T, Uchida H, Shimojima M, Kirikae T.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00124-19. doi: 10.1128/AAC.00124-19. Print 2019 Jun.

PMID:
30962328
16.

Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice.

Norton TD, Zhen A, Tada T, Kim J, Kitchen S, Landau NR.

Mol Ther. 2019 May 8;27(5):960-973. doi: 10.1016/j.ymthe.2019.03.008. Epub 2019 Mar 15.

PMID:
30962161
17.

Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios.

Tada T, Kumada T, Toyoda H, Yasuda S, Koyabu T, Nakashima M.

Nutr Cancer. 2019 Apr 6:1-10. doi: 10.1080/01635581.2019.1597905. [Epub ahead of print]

PMID:
30955354
18.

Clinical Characteristics and Outcomes of Venous Thromboembolisms According to an Out-of-Hospital vs. In-Hospital Onset - From the COMMAND VTE Registry.

Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators.

Circ J. 2019 May 24;83(6):1377-1384. doi: 10.1253/circj.CJ-18-1314. Epub 2019 Mar 30.

19.

Long-Term Outcomes of Drug-Eluting Stent Implantation After Rotational Atherectomy for Left Main Coronary Artery Bifurcation Lesions.

Fuku Y, Kadota K, Toyofuku M, Morimoto T, Ohya M, Higami H, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators.

Am J Cardiol. 2019 Jun 1;123(11):1796-1805. doi: 10.1016/j.amjcard.2019.03.002. Epub 2019 Mar 9.

PMID:
30929770
20.

Cross-sectional and longitudinal relationship between physical fitness and academic achievement in Japanese adolescents.

Sasayama K, Nonoue K, Tada T, Adachi M.

Eur J Sport Sci. 2019 Mar 28:1-10. doi: 10.1080/17461391.2019.1593509. [Epub ahead of print]

PMID:
30922177
21.

Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.

Chuma M, Toyoda H, Matsuzaki J, Saito Y, Kumada T, Tada T, Kaneoka Y, Maeda A, Yokoo H, Ogawa K, Kamiyama T, Taketomi A, Matsuno Y, Yazawa K, Takeda K, Kunisaki C, Ogushi K, Moriya S, Hara K, Nozaki A, Kondo M, Fukuda H, Numata K, Tanaka K, Maeda S, Sakamoto N.

Hepatol Res. 2019 Mar 28. doi: 10.1111/hepr.13338. [Epub ahead of print]

PMID:
30920086
22.

Application of convolutional neural networks for evaluating Helicobacter pylori infection status on the basis of endoscopic images.

Shichijo S, Endo Y, Aoyama K, Takeuchi Y, Ozawa T, Takiyama H, Matsuo K, Fujishiro M, Ishihara S, Ishihara R, Tada T.

Scand J Gastroenterol. 2019 Feb;54(2):158-163. doi: 10.1080/00365521.2019.1577486. Epub 2019 Mar 17.

PMID:
30879352
23.

miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.

Ashizawa M, Okayama H, Ishigame T, Thar Min AK, Saito K, Ujiie D, Murakami Y, Kikuchi T, Nakayama Y, Noda M, Tada T, Endo H, Fujita S, Sakamoto W, Saito M, Saze Z, Momma T, Ohki S, Mimura K, Kono K.

Mol Cancer Res. 2019 Jun;17(6):1403-1413. doi: 10.1158/1541-7786.MCR-18-0831. Epub 2019 Mar 14.

PMID:
30872332
24.

Triptycene Tripods for the Formation of Highly Uniform and Densely Packed Self-Assembled Monolayers with Controlled Molecular Orientation.

Ishiwari F, Nascimbeni G, Sauter E, Tago H, Shoji Y, Fujii S, Kiguchi M, Tada T, Zharnikov M, Zojer E, Fukushima T.

J Am Chem Soc. 2019 Apr 10;141(14):5995-6005. doi: 10.1021/jacs.9b00950. Epub 2019 Mar 21.

25.

Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan.

Takaguchi K, Toyoda H, Tsutsui A, Suzuki Y, Nakamuta M, Imamura M, Senoh T, Nagano T, Tada T, Tachi Y, Hiraoka A, Michitaka K, Shibata H, Joko K, Okubo H, Tsuji K, Takaki S, Watanabe T, Ogawa C, Chayama K, Kumada T, Kudo M, Kumada H.

J Gastroenterol. 2019 Mar 8. doi: 10.1007/s00535-019-01568-8. [Epub ahead of print]

PMID:
30848363
26.

Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Thromb Res. 2019 May;177:1-9. doi: 10.1016/j.thromres.2019.02.029. Epub 2019 Feb 25.

PMID:
30825719
27.

Pseudomonas asiatica sp. nov., isolated from hospitalized patients in Japan and Myanmar.

Tohya M, Watanabe S, Teramoto K, Uechi K, Tada T, Kuwahara-Arai K, Kinjo T, Maeda S, Nakasone I, Zaw NN, Mya S, Zan KN, Tin HH, Fujita J, Kirikae T.

Int J Syst Evol Microbiol. 2019 May;69(5):1361-1368. doi: 10.1099/ijsem.0.003316. Epub 2019 Feb 27.

PMID:
30810522
28.

Molecular Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Hospitals in Myanmar.

Tada T, Hishinuma T, Watanabe S, Uchida H, Tohya M, Kuwahara-Arai K, Mya S, Zan KN, Kirikae T, Tin HH.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02397-18. doi: 10.1128/AAC.02397-18. Print 2019 May.

PMID:
30803967
29.

Practical analysis of pars flaccida cholesteatoma with classification and staging system proposed by Japan Otological Society: a comparative study.

Komori M, Tada T, Koizumi H, Takahashi M, Sanpei S, Morino T, Motegi M, Miura M, Yamamoto K, Sakurai Y, Yaguchi Y, Yamamoto Y, Kojima H.

Acta Otolaryngol. 2018 Nov;138(11):977-980. doi: 10.1080/00016489.2018.1498593. Epub 2019 Feb 11.

PMID:
30744456
30.

Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.

Kariyama K, Nouso K, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Wakuta A, Oonishi A, Kumada T, Kudo M, Group OBOTRPEFHRS, Group H.

Cancers (Basel). 2019 Feb 10;11(2). pii: E203. doi: 10.3390/cancers11020203.

31.

[Laparoscopic Endoscopic Cooperative Surgery(LECS)for Duodenal Tumors].

Ohki S, Hikichi T, Momma T, Watanabe K, Nakamura J, Yamada R, Ujiie D, Nirei A, Tada T, Hanayama H, Watanabe Y, Hayase S, Gonda K, Saze Z, Kono K.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2024-2026. Japanese.

PMID:
30692432
32.

[A Case of Esophageal Cancer with Cervical Lymph Node Recurrence Six Years after Complete Response to Definitive Chemoradiotherapy].

Fujita S, Ohki S, Hayase S, Ujiie D, Kikuchi T, Tada T, Hanayama H, Okayama H, Sakamoto W, Endo H, Saito M, Gonda K, Saze Z, Momma T, Kono K.

Gan To Kagaku Ryoho. 2018 Dec;45(13):1821-1823. Japanese.

PMID:
30692365
33.

Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices.

Iijima H, Tada T, Kumada T, Kobayashi N, Yoshida M, Aoki T, Nishimura T, Nakano C, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Ide YH, Hirota S, Fujimoto J, Nishiguchi S.

Hepatol Res. 2019 Jan 24. doi: 10.1111/hepr.13319. [Epub ahead of print]

PMID:
30680865
34.

Influence of baseline anemia on long-term clinical outcomes in patients with venous thromboembolism: from the COMMAND VTE registry.

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

J Thromb Thrombolysis. 2019 Apr;47(3):444-453. doi: 10.1007/s11239-018-1791-2.

PMID:
30673941
35.

Automatic detection of erosions and ulcerations in wireless capsule endoscopy images based on a deep convolutional neural network.

Aoki T, Yamada A, Aoyama K, Saito H, Tsuboi A, Nakada A, Niikura R, Fujishiro M, Oka S, Ishihara S, Matsuda T, Tanaka S, Koike K, Tada T.

Gastrointest Endosc. 2019 Feb;89(2):357-363.e2. doi: 10.1016/j.gie.2018.10.027. Epub 2018 Oct 25.

PMID:
30670179
36.

Membrane-associated RING-CH (MARCH) 1 and 2 are MARCH family members that inhibit HIV-1 infection.

Zhang Y, Tada T, Ozono S, Yao W, Tanaka M, Yamaoka S, Kishigami S, Fujita H, Tokunaga K.

J Biol Chem. 2019 Mar 8;294(10):3397-3405. doi: 10.1074/jbc.AC118.005907. Epub 2019 Jan 10.

PMID:
30630952
37.

Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all-oral direct acting antivirals in patients with chronic hepatitis C virus infection.

Nakashima M, Toyoda H, Tada T, Mizuno K, Iio E, Tanaka Y, Sugiyama T, Yoshimura T, Kumada T.

Hepatol Res. 2019 May;49(5):512-520. doi: 10.1111/hepr.13311. Epub 2019 Feb 7.

PMID:
30628746
38.

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis.

Hiraoka A, Kumada T, Kariyama K, Takaguchi K, Atsukawa M, Itobayashi E, Tsuji K, Tajiri K, Hirooka M, Shimada N, Shibata H, Ishikawa T, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Itokawa N, Imai M, Joko K, Hiasa Y, Michitaka K; Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Cancer Med. 2019 Jan;8(1):137-146. doi: 10.1002/cam4.1909. Epub 2018 Dec 21.

39.

Emergence in Japan of an isolate of Klebsiella pneumoniae co-harbouring blaKPC-2 and rmtB.

Uchida H, Tada T, Tohya M, Sugahara Y, Kato A, Miyairi I, Kirikae T.

J Glob Antimicrob Resist. 2018 Dec 13;17:157-159. doi: 10.1016/j.jgar.2018.11.026. [Epub ahead of print]

PMID:
30553930
40.

Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.

Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Michitaka K, Deguchi A, Ishikawa T, Imai M, Ochi H, Joko K, Shimada N, Tajiri K, Hirooka M, Koizumi Y, Hiasa Y, Tanaka J.

J Gastroenterol Hepatol. 2019 Jun;34(6):1066-1073. doi: 10.1111/jgh.14564. Epub 2019 Feb 27.

PMID:
30549320
41.

Diagnosis using deep-learning artificial intelligence based on the endocytoscopic observation of the esophagus.

Kumagai Y, Takubo K, Kawada K, Aoyama K, Endo Y, Ozawa T, Hirasawa T, Yoshio T, Ishihara S, Fujishiro M, Tamaru JI, Mochiki E, Ishida H, Tada T.

Esophagus. 2019 Apr;16(2):180-187. doi: 10.1007/s10388-018-0651-7. Epub 2018 Dec 13.

PMID:
30547352
42.

Gas reforming and tar decomposition performance of nickel oxide (NiO)/SBA-15 catalyst in gasification of woody biomass.

Inoue N, Tada T, Kawamoto K.

J Air Waste Manag Assoc. 2019 Apr;69(4):502-512. doi: 10.1080/10962247.2018.1557088. Epub 2019 Feb 11.

PMID:
30540545
43.

An improved carbapenem inactivation method, CIMTrisII, for carbapenemase production by Gram-negative pathogens.

Uechi K, Tada T, Kuwahara-Arai K, Sekiguchi JI, Yanagisawa I, Tome T, Nakasone I, Maeda S, Mya S, Zan KN, Tin HH, Kirikae T, Fujita J.

J Med Microbiol. 2019 Feb;68(2):124-131. doi: 10.1099/jmm.0.000888. Epub 2018 Dec 10.

PMID:
30526741
44.

Structures of endo-1,5-α-L-arabinanase mutants from Bacillus thermodenitrificans TS-3 in complex with arabino-oligosaccharides.

Yamaguchi A, Sogabe Y, Fukuoka S, Sakai T, Tada T.

Acta Crystallogr F Struct Biol Commun. 2018 Dec 1;74(Pt 12):774-780. doi: 10.1107/S2053230X18015947. Epub 2018 Nov 26.

PMID:
30511671
45.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.

Atsukawa M, Tsubota A, Toyoda H, Takaguchi K, Nakamuta M, Watanabe T, Tada T, Tsutsui A, Ikeda H, Abe H, Kato K, Uojima H, Ikegami T, Asano T, Kondo C, Koeda M, Okubo T, Arai T, Iwashita-Nakagawa A, Itokawa N, Kumada T, Iwakiri K.

Hepatol Res. 2019 Apr;49(4):369-376. doi: 10.1111/hepr.13292. Epub 2019 Jan 2.

PMID:
30485638
46.

Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction.

Tada T, Kumada T, Toyoda H, Kobayashi N, Sone Y, Oguri T, Kamiyama N.

AJR Am J Roentgenol. 2019 Feb;212(2):332-341. doi: 10.2214/AJR.18.20123. Epub 2018 Nov 26.

PMID:
30476453
47.

Nucleus-localized adiponectin is survival gatekeeper through miR-214-mediated AIFM2 regulation.

Cho J, Teshigawara R, Kameda M, Yamaguchi S, Tada T.

Genes Cells. 2019 Feb;24(2):126-138. doi: 10.1111/gtc.12658. Epub 2019 Jan 2.

PMID:
30474186
48.

Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235.

Hishinuma T, Tada T, Kuwahara-Arai K, Yamamoto N, Shimojima M, Kirikae T.

PLoS One. 2018 Nov 19;13(11):e0207134. doi: 10.1371/journal.pone.0207134. eCollection 2018.

49.

Detecting gastric cancer from video images using convolutional neural networks.

Ishioka M, Hirasawa T, Tada T.

Dig Endosc. 2019 Mar;31(2):e34-e35. doi: 10.1111/den.13306. Epub 2018 Dec 21. No abstract available.

PMID:
30449050
50.

Acute Coronary Syndrome With Unprotected Left Main Coronary Artery Culprit - An Observation From the AOI-LMCA Registry.

Higami H, Toyofuku M, Morimoto T, Ohya M, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kadota K, Kimura T; AOI-LMCA Stenting Registry Investigators.

Circ J. 2018 Dec 25;83(1):198-208. doi: 10.1253/circj.CJ-18-0896. Epub 2018 Nov 9.

Supplemental Content

Support Center